Literature DB >> 28398366

[Diuretic treatment in patients with chronic heart failure: evidences, experiences, and current perspectives].

Pierpaolo Pellicori1, Valentina Carubelli2.   

Abstract

Congestion is a fundamental clinical sign in patients with chronic heart failure (CHF). Diuretics are the mainstay treatment for congestion but, so far, no randomized trial has ever shown any beneficial effect of diuretics on mortality in patients with CHF. It is also unclear how and when diuretics should be up, or down titrated, or when their use can be safely stopped. In this review, we discuss current evidence regarding the clinical use of diuretics. We also highlight the need for more clinical trials to explore the short- and long-term safety, efficacy and clinical benefits of different classes of diuretics, used alone or in combination, in patients with CHF.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28398366     DOI: 10.1714/2663.27298

Source DB:  PubMed          Journal:  G Ital Cardiol (Rome)        ISSN: 1827-6806


  2 in total

1.  Direct Cardiac Actions of the Sodium Glucose Co-Transporter 2 Inhibitor Empagliflozin Improve Myocardial Oxidative Phosphorylation and Attenuate Pressure-Overload Heart Failure.

Authors:  Xuan Li; Qingguo Lu; Yunguang Qiu; Jussara M do Carmo; Zhen Wang; Alexandre A da Silva; Alan Mouton; Ana C M Omoto; Michael E Hall; Ji Li; John E Hall
Journal:  J Am Heart Assoc       Date:  2021-03-13       Impact factor: 5.501

2.  Dosage variability of veterinary drug products, containing furosemide, linked to tablet splitting.

Authors:  Lauretta Maggi; Valeria Friuli; Paola Perugini; Giorgio Musitelli; Luigi Venco
Journal:  Open Vet J       Date:  2021-09-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.